Spots Global Cancer Trial Database for memantine
Every month we try and update this database with for memantine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors | NCT04217694 | Malignant Centr... Primary Central... | Cogstate Assess... Memantine Memantine Hydro... | 4 Years - 18 Years | Mayo Clinic | |
| Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery | NCT04588246 | Anatomic Stage ... Metastatic Brea... Metastatic Dige... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Prognostic Stag... Recurrent Brain... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... | Memantine Quality-of-Life... Questionnaire A... Stereotactic Ra... Whole-Brain Rad... | 18 Years - | NRG Oncology | |
| Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery | NCT04588246 | Anatomic Stage ... Metastatic Brea... Metastatic Dige... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Prognostic Stag... Recurrent Brain... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... | Memantine Quality-of-Life... Questionnaire A... Stereotactic Ra... Whole-Brain Rad... | 18 Years - | NRG Oncology | |
| Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases | NCT02360215 | Cognitive Impai... Metastatic Mali... Solid Neoplasm | Whole brain rad... Memantine Whole brain rad... | 18 Years - | NRG Oncology | |
| Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases | NCT02360215 | Cognitive Impai... Metastatic Mali... Solid Neoplasm | Whole brain rad... Memantine Whole brain rad... | 18 Years - | NRG Oncology | |
| NTS-WBRT in Brain Metastases | NCT05013892 | Brain Metastase... | NTS-WBRT (norma... Memantine | 18 Years - | Massachusetts General Hospital | |
| Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity | NCT05834231 | Cancer | Memantine Placebo | 18 Years - 75 Years | Mansoura University | |
| Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases | NCT03550391 | Brain Metastase... | Memantine Hippocampal-avo... Stereotactic Ra... | 18 Years - | Canadian Cancer Trials Group | |
| The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy | NCT04737967 | Oncology Pain Chemotherapy-in... | Venlafaxine Memantine | 18 Years - | Mendel AI | |
| Memantine for Recurrent Glioblastoma | NCT01260467 | Glioblastoma | memantine | 18 Years - | University of Rochester | |
| Glutamate Inhibitors in Glioblastoma | NCT05664464 | Glioblastoma | Gabapentin Sulfasalazine Memantine Temozolomide Radiotherapy | 18 Years - | University of Zurich | |
| Memantine for Recurrent Glioblastoma | NCT01260467 | Glioblastoma | memantine | 18 Years - | University of Rochester | |
| Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery | NCT04588246 | Anatomic Stage ... Metastatic Brea... Metastatic Dige... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Prognostic Stag... Recurrent Brain... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... | Memantine Quality-of-Life... Questionnaire A... Stereotactic Ra... Whole-Brain Rad... | 18 Years - | NRG Oncology | |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors | NCT04217694 | Malignant Centr... Primary Central... | Cogstate Assess... Memantine Memantine Hydro... | 4 Years - 18 Years | Mayo Clinic | |
| The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy | NCT04737967 | Oncology Pain Chemotherapy-in... | Venlafaxine Memantine | 18 Years - | Mendel AI |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
